University Health Network Toronto
Welcome,         Profile    Billing    Logout  
 17 Trials 
5 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Feld, Jordan
D-LIVR, NCT03719313 / 2018-003167-54: Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2a

Completed
3
407
Europe, Canada, US, RoW
Lonafarnib, EBP994, Sarasar, LNF, Ritonavir, Norvir, RTV, PEG IFN-alfa-2a, Pegasys, pegylated interferon-alfa, Placebo Lonafarnib, Placebo Ritonavir
Eiger BioPharmaceuticals
Hepatitis Delta Virus
10/22
03/23
B-Fine, NCT04544956: A Mechanistic Study of GSK3228836 With Fine Needle Aspiration (FNA) in Participants With Chronic Hepatitis B

Completed
2
12
Europe, Canada, US
GSK3228836, Nucleos(t)ide therapy
GlaxoSmithKline
Hepatitis B
11/23
11/23
B-Sure, NCT04954859 / 2021-000554-26: Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants

Recruiting
2
450
Europe, Canada, Japan, US, RoW
Bepirovirsen, Placebo
GlaxoSmithKline, GlaxoSmithKline Research & Development Limited
Hepatitis B
02/29
02/29
RAPID-HCV, NCT04677153: Rapid HCV Treatment Access for Persons Who Use Drugs

Completed
N/A
124
Canada, US
Test and treat plus peer mentors, On-site treatment with peer support HCV treatment implementation strategy, Usual care, Standard of care referral HCV treatment implementation strategy
Johns Hopkins University, AbbVie
Hepatitis C Virus Infection, Response to Therapy of
02/24
09/24
Price, Jennifer AD
RAPID-HCV, NCT04677153: Rapid HCV Treatment Access for Persons Who Use Drugs

Completed
N/A
124
Canada, US
Test and treat plus peer mentors, On-site treatment with peer support HCV treatment implementation strategy, Usual care, Standard of care referral HCV treatment implementation strategy
Johns Hopkins University, AbbVie
Hepatitis C Virus Infection, Response to Therapy of
02/24
09/24
Kwok, Julian
No trials found

Download Options